These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8381650)

  • 61. [Extrahepatic manifestations of hepatitis C virus].
    Tohme A; Haddad F; Malek N; Ghayad E
    J Med Liban; 1998; 46(2):84-8. PubMed ID: 10095833
    [No Abstract]   [Full Text] [Related]  

  • 62. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 63. Does maternal-neonatal transmission of hepatitis C occur--are we sure?
    Rosenthal P
    Am J Gastroenterol; 1993 Aug; 88(8):1284-6. PubMed ID: 7687821
    [No Abstract]   [Full Text] [Related]  

  • 64. [Virus-like particles in patients with systemic lupus erythematosus, dermatomyositis and Sjogren's disease].
    Levo Y; Ben-Bassat M
    Harefuah; 1975 Feb; 88(4):153-6. PubMed ID: 1123191
    [No Abstract]   [Full Text] [Related]  

  • 65. [Electron microscopy demonstration of "virus-like" inclusion bodies in myoepithelial sialadenitis within the scope of "Sjögren's" syndrome].
    Albegger KW; Auböck L
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1972; 203(2):153-65. PubMed ID: 4646756
    [No Abstract]   [Full Text] [Related]  

  • 66. Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjögren's syndrome.
    Sorrentino D; Ferraccioli GF; DeVita S; Labombarda A; Boiocchi M; Bartoli E
    Blood; 1997 Sep; 90(5):2116-7. PubMed ID: 9292556
    [No Abstract]   [Full Text] [Related]  

  • 67. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C
    Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196
    [No Abstract]   [Full Text] [Related]  

  • 68. Opportunistic infection due to unexplained CD4+ lymphocytopenia and associated Sjögren's syndrome.
    Schattner A; Friedman J; Bentwich Z
    Rheumatology (Oxford); 2004 Jan; 43(1):111-2. PubMed ID: 14681566
    [No Abstract]   [Full Text] [Related]  

  • 69. Periodontal status and serum antibody responses to oral microorganisms in Sjögren's syndrome.
    Celenligil H; Eratalay K; Kansu E; Ebersole JL
    J Periodontol; 1998 May; 69(5):571-7. PubMed ID: 9623900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome.
    Pflugfelder SC; Crouse CA; Atherton SS
    Adv Exp Med Biol; 1994; 350():641-6. PubMed ID: 8030548
    [No Abstract]   [Full Text] [Related]  

  • 71. Hepatitis C virus antibody in Kuwait.
    al-Nakib B; Koshy A; Kaloui M; al-Ramahi S; al-Mufti S; Radhakrishnan S; al-Nakib W
    Vox Sang; 1992; 63(1):75-6. PubMed ID: 1384237
    [No Abstract]   [Full Text] [Related]  

  • 72. New developments in Sjögren's syndrome.
    Kater L; de Wilde PC
    Curr Opin Rheumatol; 1992 Oct; 4(5):657-65. PubMed ID: 1419499
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clinical significance of hepatitis C virus antibody in diagnosis of hepatitis C].
    Furuta S
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):997-1000. PubMed ID: 2172428
    [No Abstract]   [Full Text] [Related]  

  • 74. Hepatitis C virus (HCV) antibodies in the rheumatic diseases.
    Tanaka M; Kobayashi S; Tajima M; Hatta S; Isobe Y; Hashimoto H; Hirose S
    Clin Exp Rheumatol; 1991; 9(3):308-9. PubMed ID: 1652389
    [No Abstract]   [Full Text] [Related]  

  • 75. [A possible role of hepatitis C virus in the pathogenesis of Sjogren's syndrome].
    Madaliński K; Dzierzanowska-Fangrat K; Jóźwiak P; Puszczewicz M; Zimmermann-Górska I
    Pol Arch Med Wewn; 2002 Feb; 107(2):167-71. PubMed ID: 12107973
    [No Abstract]   [Full Text] [Related]  

  • 76. The oral ecology of patients with severe Sjögren's syndrome.
    MacFarlane TW
    Microbios; 1984; 41(160):99-106. PubMed ID: 6738376
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Chronic hepatitis C and Gougerot-Sjogren syndrome. Apropos of a case].
    Poët JL; Garnier PP; Tonolli-Serabian I; Mattei JP; Gauthier A; Roux H
    Rev Rhum Ed Fr; 1993 Apr; 60(4):305-7. PubMed ID: 8167629
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral yeast colonization in patients with primary and secondary Sjögren's syndrome.
    Medeiros CCG; Dos Anjos Borges LG; Cherubini K; Salum FG; Medina da Silva R; de Figueiredo MAZ
    Oral Dis; 2018 Oct; 24(7):1367-1378. PubMed ID: 29782688
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
    Sène D; Ghillani-Dalbin P; Limal N; Thibault V; van Boekel T; Piette JC; Cacoub P
    Ann Rheum Dis; 2006 Mar; 65(3):394-7. PubMed ID: 16474032
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interview with Haralampos M. Moutsopoulos. What's going to happen as far as the natural history of Sjögren's syndrome is concerned?. Interview by Pierre Youinou.
    Moutsopoulos HM
    Ann Med Interne (Paris); 1994; 145(3):175-6. PubMed ID: 8092631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.